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Group A Streptococcus (GAS) is a human-specific bacterial pathogen responsible for serious morbidity andmortality worldwide.
The hyaluronic acid (HA) capsule of GAS is a major virulence factor, contributing to bloodstream survival through resistance to
neutrophil and antimicrobial peptide killing and to in vivo pathogenicity. Capsule biosynthesis has been exclusively attributed
to the ubiquitous hasABC hyaluronan synthase operon, which is highly conserved across GAS serotypes. Previous reports indi-
cate that hasA, encoding hyaluronan synthase, and hasB, encoding UDP-glucose 6-dehydrogenase, are essential for capsule pro-
duction in GAS. Here, we report that precise allelic exchange mutagenesis of hasB in GAS strain 5448, a representative of the
globally disseminated M1T1 serotype, did not abolish HA capsule synthesis. In silicowhole-genome screening identified a puta-
tive HasB paralog, designated HasB2, with 45% amino acid identity to HasB at a distant location in the GAS chromosome. In
vitro enzymatic assays demonstrated that recombinant HasB2 is a functional UDP-glucose 6-dehydrogenase enzyme. Mutagene-
sis of hasB2 alone slightly decreased capsule abundance; however, ahasBhasB2 double mutant became completely acapsular.
We conclude that HasB is not essential for M1T1 GAS capsule biogenesis due to the presence of a newly identified HasB paralog,
HasB2, which most likely resulted from gene duplication. The identification of redundant UDP-glucose 6-dehydrogenases un-
derscores the importance of HA capsule expression for M1T1 GAS pathogenicity and survival in the human host.
The Gram-positive bacterial pathogen Streptococcus pyogenes,commonly referred to as group A Streptococcus (GAS), is the
etiologic agent of numerous human diseases. Clinical manifesta-
tions range from benign skin infections, such as impetigo and
pharyngitis (700 million cases per year worldwide), to poten-
tially life-threatening invasive infections, including necrotizing
fasciitis and streptococcal toxic shock-like syndrome (650,000
cases per year worldwide), with an associated mortality of 25%
(9). Serious postinfectious sequelae, including acute poststrepto-
coccal glomerulonephritis and rheumatic fever, may also develop
following recurrent GAS infections. The resurgence of severe in-
vasive GAS diseases over the past 30 years (10) correlates with the
isolation of the globally disseminated serotype M1T1 GAS.
GAS strains express an assortment of surface-associated mole-
cules that contribute to pathogenesis, including a high-molecular-
mass hyaluronic acid (HA) capsule consisting of a polymer of
alternating glucuronic acid and -1,3-linked N-acetylgluco-
samine residues (34). The capsule is essentially identical to mam-
malian HA expressed abundantly on cell surfaces, connective tis-
sue, and the extracellular matrix milieu. The molecular mimicry
of host structures enables GAS to avoid detection by the host im-
mune system (14) and accounts for the poor immunogenicity of
the GAS capsule in humans (27). A primary role of HA capsule is
to provide a physical barrier that promotes bacterial survival
through interference with host immune responses, including an-
tibody access to epitopes on the bacterial surface (21), comple-
ment deposition (16), and opsonophagocytosis (7, 16, 26). Also,
capsule promotes GAS survival in neutrophil extracellular traps
(NETs) through enhanced resistance to cathelicidin antimicrobial
peptide LL-37, a major constituent of NETs (11). Consequently,
acapsular GAS mutants are sensitive to phagocytic killing in hu-
man blood in vitro and have reduced virulence in murine models
of GAS invasive infection compared with encapsulated wild-type
(WT) strains (36, 47–49). In addition to its role in systemic infec-
tion, capsular HA binds CD44 on host cell keratinocytes to pro-
mote GAS adherence to pharyngeal epithelial cells (40) and con-
tributes to pharyngeal colonization in a mouse model (15).
Together, these studies confirm a central role for capsule in GAS
pathogenicity.
HA capsule biosynthesis in GAS is coordinated by the ubiqui-
tous and highly conserved hasABC operon (13, 22). Hyaluronate
synthase (encoded by hasA) is a membrane-associated enzyme
that forms the linear HA polymer by the alternate addition of
N-acetylglucosamine and glucuronic acid residues from their re-
spective UDP-sugar precursors (19, 23). UDP-glucose 6-dehydro-
genase (encoded by hasB) forms UDP-glucuronic acid from UDP-
glucose in the presence of NAD (24), while UDP-glucose
pyrophosphorylase (glucose-1-phosphate uridylyltransferase; en-
coded by hasC) catalyzes the production of UDP-glucose from
glucose-1-phosphate and UTP (12). The hasABC operon is tran-
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scribed as a single mRNA transcript from a promoter located up-
stream of the first gene in the operon, hasA (1, 12), with maximal
expression occurring in exponential growth phase (13, 45). The
region of10 to35 of the hasABC promoter plays a central role
in determining promoter strength and capsule expression levels in
GAS (1).
GAS capsule expression is strongly upregulated in human
blood (29, 39), and highly encapsulated, or mucoid, isolates are
frequently associated with pharyngeal persistence, acute rheu-
matic fever, and severe invasive human diseases (32, 41). Capsule
is also indispensable for the in vivo selection of hypervirulent
M1T1 GAS variants harboring mutations within the two-compo-
nent regulator covRS (11), also known as csrRS (5, 35). Mutations
within covRS transcriptionally affect 10 to 15% of the genes
within the GAS genome (28, 43), resulting in enhanced expression
of the hasABC operon and an array of neutrophil resistance genes
(10, 44). Enhanced HA capsule expression concomitantly reduces
adherence to keratinocytes, extracellular matrix binding, and bio-
film formation (31), preventing the dissemination of hyperviru-
lent covRSmutant M1T1 GAS among the human population (31).
Previous reports concluded that HasA and HasB are uniquely
required for GAS capsule production (3, 18), while HasC is not
essential (3, 19). However, these studies inferred the contribution
of HasB to GAS HA production by using either heterologous ex-
pression systems or Tn916 transposon mutants with polar effects
on downstream gene expression levels. Here, we targeted the hasB
gene in serotype M1T1 GAS by precise allelic exchange mutagen-
esis to directly address the role of HasB in capsule biosynthesis.
Our results indicate that HasB is a nonessential enzyme for cap-
sule synthesis in M1T1 GAS. We report the identification and
characterization of a novel UDP-glucose 6-dehydrogenase, desig-
nated HasB2, which can compensate for a nonfunctional HasB
enzyme.
MATERIALS AND METHODS
Bacterial strains and growth conditions. GAS strain 5448, a representa-
tive of the globally disseminated serotype M1T1 clone, was isolated from
a patient with toxic shock-like syndrome and necrotizing fasciitis (33) and
is here designated the wild-type (WT) strain. The isogenic hasA inser-
tional mutant of this WT strain was described previously (31). GAS strains
were routinely propagated at 37°C on Todd-Hewitt agar (THA) or in
liquid cultures of Todd-Hewitt broth (THB) (Hardy Diagnostics) under
static conditions. When required, growth medium was supplemented
with 5 g/ml erythromycin (Em) or 2 g/ml chloramphenicol (Cm).
Escherichia coli strain BL21 Star (DE3) (Invitrogen) was grown at 37°C on
Luria-Bertani (LB) (Hardy Diagnostics) agar with 50 g/ml kanamycin
(Km) or in liquid cultures of LB supplemented with 50 g/ml Km with
orbital rotation at 220 rpm.
Allelic exchange mutagenesis of hasB. To construct the precise in-
frame allelic exchange mutant of hasB (GenBank GeneID 3571024),
the upstream and downstream regions of hasB were PCR amplified
from the WT GAS chromosome using the primer pair hasB-up-for
(5=-GGCTCTAGAGGACGCACTGTCTACCAATC-3=) and hasB-up-
rev-cat (5=-GGTGGTATATCCAGTGATTTTTTTCTCCATCAATCTCT
TCCTCATTAAAA-3=, with a 30-bp 5= extension matching the 5= end of
the chloramphenicol acetyltransferase [cat] gene) and the pair hasB-dn-
for-cat (5=-ATCTGCGATGAGTGGCAGGGCGGGGCGTAACCATGT
CTTCATCTATAACA-3=, with 30 bp 5= extension matching 3= end of the
cat gene) and hasB-dn-rev (5=-GCCGGATCCCCTCTAATTTCAACAGT
TCA-3=). Purified upstream and downstream PCR products, in addition
to the cat PCR product, were amplified with Pfu Ultra II (Stratagene) to
yield a fusion product in which cat precisely replaced hasB. This fusion
product was cloned into the temperature-sensitive Emr plasmid pHY304
(38) and electroporated into the WT strain (17), and the transformants
were selected by growth on THA supplemented with 5 g/ml Em for 2
days at 30°C. Single crossover recombination was selected for by shifting
to the nonpermissive temperature (37°C) while maintaining Em selection
and was confirmed by PCR. Selective pressure was relaxed by serial pas-
sage at 30°C without antibiotics, and double crossovers were identified by
screening for a Cmr Ems phenotype. The in-frame allelic exchange of hasB
with cat in the GAS chromosome was verified by PCR using hasB- and
cat-specific primers.
Insertional mutagenesis of hasB2. Genetic mutation of hasB2
(GenBank GeneID 3572465) in GAS was performed by PCR amplifying a
445-bp fragment starting from 122 bp downstream of the hasB2ATG start
codon using primers Forw-XhoI (5=-GCGCTCGAGGCAATCCCCTCTT
AAAGAAGCAG-3=) and Rev-BamHI (5=-GCGGGATCCTCGCTTCTG
CTTCAGAAGAGCC-3=) (underlining indicates restriction sequences).
The fragment was cloned into temperature-sensitive plasmid pHY304 and
transformed into the electrocompetent WT or hasB strain, and single
crossover mutants hasB2 and hasB hasB2 were generated following
temperature shifting and antibiotic selection (Emr), as described above.
Plasmid integration was confirmed by PCR using primers Forw-XhoI and
Rev-confirm (5=-CCGAAAGAAGGATTATTGTGCG-3=). Revertant
strains, here designated the hasB2R1 and hasB hasB2R1 strains, were
generated by serial passage at 30°C for 2 days in THB without antibiotic
selection, prior to the plating of serial dilutions onto THA and overnight
incubation at 37°C. Loss of the integrated plasmid from the chromosome
was identified by screening for Ems colonies. Restoration of the hasB2
allele was confirmed by the HA capsule assay and PCR using primers Forw
(5=-GGCTGGAGACAAGAACTAAAGACT-3=) and Rev-confirm to ob-
tain a 974-bp amplicon.
Cloning and recombinant protein expression. The hasB2 and hasB
genes were PCR amplified from the WT GAS chromosome using the
primer pair HasB2-F (5=-GGGAATTCATGAAAATTACAGTTGTAG-
3=) and HasB2-R (5=-GGGAATTCTTAATCATACTGAAAAATATCA-
3=) and the pair HasB-F (5=-GGGAATTCATGAAAATAGCAGTTG-3=)
and HasB-R (5=-GGGAATTCCTAGTCTCTATTAAAAATATCTCTAC-
3=). Purified PCR products were cloned into the Kmr 6His tag expres-
sion plasmid pET-28b (Merck), transformed into chemically competent
E. coli BL21 Star (DE3) (Invitrogen), and incubated overnight at 37°C
with shaking (220 rpm) in LB broth containing 50 g/ml Km. The next
day, cultures were diluted 1:20 into fresh LB–50 g/ml Km and grown to
an optical density at 600 nm (OD600) of 0.6, and recombinant protein
overexpression was induced with isopropyl -D-1-thiogalactopyranoside
(IPTG) at a final concentration of 1 mM for 4 h. Bacteria were pelleted by
centrifugation at 3,220  g for 10 min and stored at 20°C prior to
UDP-glucose 6-dehydrogenase enzymatic assays.
UDP-glucose 6-dehydrogenase enzymatic assay.UDP-glucose 6-de-
hydrogenase assays were performed as described previously (42). Follow-
ing IPTG induction of recombinant protein expression inE. coliBL21 Star
(DE3) described above, bacterial pellets from 10-ml cultures were resus-
pended in 1 ml of phosphate buffer (50 mM Na2HPO4 · KH2PO4, pH 7.0).
Bacterial cells were mechanically disrupted on ice by sonication with the
550 Sonic Dismembrator (Fisher Scientific) and a microtip probe (20 30-s
bursts on setting 4.5, with 30-s rests on ice between bursts). Bacterial
debris was pelleted by centrifugation at 13,000 g for 10 min at 4°C, and
the supernatant was harvested for use as crude enzyme. The protein con-
centration of the crude extract was determined using a Bio-Rad detergent-
compatible (DC) protein assay kit. Enzymatic assays were performed in
96-well flat-bottom plates (Corning) by adding 5 l of crude enzyme to
195 l of 50 mM phosphate buffer (Na2HPO4 · KH2PO4, pH 7.0) con-
taining 33 mM MgCl2, 5 mM dithiothreitol (DTT), 5 mM UDP-glucose
(Sigma-Aldrich), and 0.5 mM NAD (Sigma-Aldrich). The reduction of
NAD at 340 nm was monitored spectrophotometrically at 37°C using a
SpectraMax 250 (Molecular Devices), with measurements taken every 30
s for 1 h. The enzymatic reaction rate was calculated from the initial linear
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portion of the curve (reduction of NAD versus time). The net change in
A340 per minute (total change  background) was divided by the molar
absorptivity of NADH at 340 nm (6,220 M1 cm1) and the path length
(0.6 cm for Costar 96-well flat-bottom plates), multiplied by the reaction
volume (2  106 liters), and then divided by the total protein in the
crude enzyme extract (mg). The specific enzyme activity of UDP-glucose
6-dehydrogenase was expressed as micromoles of NADH produced per
min per mg of protein.
HA capsule quantification. Two independent assays were used to
quantify HA capsule expression in mid-logarithmic-phase cultures. The
first method measured cell-associated HA polysaccharide concentration
using an HA quantitative test kit (Corgenix), as previously described (31).
In the second method, we assessed HA capsule expression by flow cytom-
etry using hyaluronan-binding protein (HABP) (Calbiochem). Bacteria
were grown to an OD600 of0.4, pelleted by centrifugation at 3,220
g for 10 min, and resuspended in HEPES buffer (pH 7.4) containing 5
mM CaCl2, 2.5 mM MgCl2, and 0.1% bovine serum albumin (BSA)
(HEPES– 0.1% BSA) to an OD600 of 0.4 (1  10
8 CFU/ml). A
total of 100 l of this bacterial suspension was pelleted and stained
with biotinylated HABP for 20 min at 37°C under shaking conditions.
After samples were washed, they were incubated with phycoerythrin
(PE)-conjugated streptavidin (SA) (Jackson ImmunoResearch) for 30
min at room temperature. After a final wash, bacteria were resus-
pended in HEPES– 0.1% BSA and analyzed by flow cytometry. Data
represent pooled values from two independent experiments per-
formed in triplicate and normalized to the SA-PE control.
Bioinformatic analyses. The M1T1 theoretical proteome (i.e., all
predicted gene products of the M1T1 genome) was searched for simi-
larity to HasA, HasB, and HasC by BLAST-P similarity analysis (2). In
addition, the M1T1 GAS genome was rescreened against these three
proteins for any potential unannotated proteins by tBLAST-N analysis
(2). Operon similarity and chromosomal clustering/colocalization
analyses were performed by the Compare Region tool of the SEED
database (http://pubseed.theseed.org/seedviewer.cgi) (37). Sequence
comparison and phylogenetic analyses were performed on the Phylog-
eny.FR server (http://www.phylogeny.fr/) (20). Briefly, MUSCLE (25)
was used for multiple sequence alignment, PhyML (30) was used for
maximum-likelihood phylogenetic distance and branch support value
calculations, and, finally, maximum-likelihood phylograms were
drawn by FigTree (http://tree.bio.ed.ac.uk/software/figtree).
Superposition of the theoretical HasB2 structure on the resolved
three-dimensional (3D) HasB structure (8) was performed using the
Cn3D visualization program (46), available at the National Center for
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/).
Functional domains were identified by searches against Pfam database
(http://pfam.sanger.ac.uk/). Transmembrane domains were predicted by
searching the TMHMM server, version 2.0 (http://www.cbs.dtu.dk
/services/TMHMM/). Signal peptide prediction was undertaken using the
SignalP, version 4.0, server (http://www.cbs.dtu.dk/services/SignalP/).
Statistical analyses. Capsular expression levels, HABP binding, and
UDP-glucose 6-dehydrogenase assays were compared by one-way analy-
sis of variance (ANOVA). Statistical significance was accepted at a P value
FIG 1 HasB is not essential for capsule production. (A) Quantitation of capsule expression of mid-log-phase M1T1 GAS WT and single hasA and hasB mutant
strains. Data denote the means  standard errors of the means of pooled data from two independent experiments performed in duplicate. Asterisks indicate
values that are statistically significantly different (***, P 	 0.001). bd, below detection. (B) Genomic organization of the has operon and hasB2 gene, which
encodes a putative HasB paralog in M1T1 GAS. Schematic representations of the genomic regions are not drawn to scale. (C) A maximum-likelihood phylogram
of HasB2 and a representative set of its homologs indicate a clear distinction between HasB and HasB2. Branch support values are indicated. The plasmid-
encoded HasB homolog in Bacillus anthracis seems to be equally distant to both paralogs.
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of 	0.05. All statistical analyses were performed using GraphPad Prism,
version 5.0b (GraphPad Software Inc.).
RESULTS
Capsular expression levels of hasA and hasBmutants. Previous
work reported essential roles for both HasA (hyaluronate syn-
thase) and HasB (UDP-glucose 6-dehydrogenase) in capsule pro-
duction (3, 18). We set out to verify these findings using individual
has gene mutants in the genetic background of M1T1 GAS. Com-
pared to the WT, the hasA mutant was deficient in cell-associ-
ated HA capsule (Fig. 1A), corroborating an essential role for hasA
in GAS capsule biosynthesis (18). In contrast, precise allelic re-
placement of the hasB gene with the chloramphenicol acetyltrans-
ferase (cat) gene in the WT M1T1 chromosome reduced, but did
not abolish, capsule production (Fig. 1A). These results indicated
(i) that hasB was not essential for HA capsule synthesis and (ii)
that M1T1 GAS must express an additional enzyme with func-
tional UDP-glucose 6-dehydrogenase activity.
Genome-wide screening for aHasBparalog.A previous report
on the Has operon of Streptococcus zooepidemicus suggested the pos-
sibility of a hasB paralog in GAS (6). To identify a functional HasB
paralog in the M1T1 GAS genome, we used a computational ge-
nome-wide screening analysis of published GAS genomes. BLAST-P
interrogation of all predicted GAS proteins with the HasB sequence
from M1T1 GAS strain MGAS5005 (NCBI protein accession number
YP_283215.1) as a query identified a putative UDP-glucose 6-dehy-
drogenase, designated M5005_Spy0449 (NCBI accession number
YP_281812.1), which shares 45.3% amino acid sequence identity
with HasB (Fig. 2A). The gene encoding M5005_Spy0449, here des-
ignatedhasB2, consists of 1,158 bp (385 amino acids) and is located in
a distinct genomic region0.46 Mbp upstream of the hasABC syn-
thesis operon (Fig. 1B). This region is highly conserved among all GAS
genome sequences and consists of a small open reading frame (ORF)
encoding a hypothetical protein,hasB2, and amefEhomolog encoding a
predicted macrolide efflux protein. Interestingly, the extended region
surroundinghasB2 is dissimilar in GAS strains (Fig. 1B) and is disrupted
byashortmobileelement,withcombinedphage-andplasmid-likegenes
(Table 1 and Fig. 1B). Examination of the Atomic Regulon Data, com-
puted from published microarray results (http://pubseed.theseed.org
FIG 2 Alignment and 3D overlay of HasB and HasB2. (A) ClustalW alignment of HasB (GenBank GeneID 3571024) and its paralog HasB2 (GenBank GeneID
3572465) from serotype M1T1 GAS strain MGAS5005 (43). HasB2 is 45.3% identical to HasB at the amino acid level. Asterisks denote identical residues; periods
indicate similar residues. Residues implicated in catalysis (yellow), NAD(H) hydrogen bonding (green), UDP-sugar binding (blue), and the dimer partner (red)
are highlighted. The gray amino acid is implicated in catalysis and NAD(H) hydrogen bonding, while the orange amino acid is implicated in UDP-sugar binding
(8). (B) HasB2 is predicted to have structural similarity to HasB. Superposition of HasB2 on the resolved 3D structure of HasB (8) was performed with Cn3D
software (46). Sequence conservation is shown as follows: identical residues, red; similar or nonidentical residues, blue). Amino acid residues in the catalytic
domain (T118, E141, E145, K204 N208, C260, and D264 of HasB) are indicated in yellow, beta-sheets are in purple, and alpha helices are in green (based on
Campbell et al. [8]).
TABLE 1 The has operon and hasB paralog genetic locus in different
GAS serotypes
Serotype
Representative
isolate
Genetic profile
hasA hasB hasC hasB2 mefE
Contiguous
mobile
element
M2 MGAS10270  Truncated    
M3 MGAS315      
M6 MGAS10394      
M12 MGAS2096      
M28 MGAS6180      
M1 SF370      
M1 MGAS5005      
M5 Manfredo      
M18 MGAS8232      
M49 NZ131      
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/seedviewer.cgi?page
 AtomicRegulon&genome
 all), indicates that
the three genes (the ORF, hasB2, and mefE) tend to be coexpressed in
GAS under various conditions, suggesting that they may form one
operon. In addition,hasB2 transcription is unchanged in covRSmutants
(data from reference 4), suggesting that hasB2 expression may not be
under regulation by the CovRS two-component system.
The hasB and hasB2 genes are ubiquitous and highly conserved
among GAS strains (Table 1); however, hasB2 was not detected in
other streptococcal or enterococcal species, except for Streptococ-
cus pseudoporcinus (Table 2). On the other hand, hasABC is con-
served in many streptococci and still present in some bacilli (Table
2), although in a different order (hasACB). Phylogenetic analyses
demonstrate that hasB is well conserved in bacteria across the
phylogenetic tree, including E. coli, Enterococcus, and some strep-
tococci (Fig. 1C). The hasB2 gene is distinct from hasB genes (Fig.
1C), suggesting that hasB2 arose as a result of gene duplication in
GAS or was acquired by horizontal gene transfer, possibly from S.
pseudoporcinus or another unsequenced bacterial strain or species.
The predicted size for HasB2 is 43.4 kDa, which is in good
agreement with the SDS-PAGE size estimate following T7 overex-
pression of hasB2 in E. coli (42 kDa) (data not shown). HasB2
lacks putative signal peptides and transmembrane domains, sim-
ilar to HasB (data not shown). Interrogation of the Pfam (version
26.0) database reveals that HasB2 and HasB share three distinct
UDP-glucose/GDP-mannose dehydrogenase family domains,
with predicted active-site residues at C250 and C260, respectively
(Table 3) (Fig. 2A). Finally, computational 3D alignments show
structural similarities for HasB2 and the published crystal struc-
ture of HasB (8) (Fig. 2B), including full conservation of the cat-
alytic residues.
HasB2 UDP-glucose 6-dehydrogenase activity. To account
for M1T1 GAS HA capsule production in the absence of a func-
tional HasB enzyme, we hypothesized that hasB2 encodes a UDP-
glucose 6-dehydrogenase. To test this hypothesis, the hasB2 and
hasB genes from WT GAS were produced as recombinant proteins
in E. coli BL21 Star (DE3), and whole-cell lysates were assayed for
UDP-glucose 6-dehydrogenase activity. E. coli cell extracts har-
boring the HasB2 and HasB expression plasmids have detectable
UDP-glucose 6-dehydrogenase enzymatic activity after IPTG in-
duction, compared to the plasmid-only control (Fig. 3). These
data demonstrate that hasB2 encodes a functional UDP-glucose
6-dehydrogenase.
Capsular expression levels ofhasB2mutants.We constructed
hasB2mutants in WT (yielding ahasB2 strain) andhasB (yield-
ing a hasB hasB2 strain) strains to determine whether HasB2
contributes to capsule synthesis in M1T1 GAS. Capsule expression
TABLE 2 Presence/absence profiles and gene order of members of the hasABC and hasB2 operons in closely related streptococci and other species
Species has operon order
Gene profile (% similaritya)
Nearby mobile element(s)hasA hasB hasC
Short
ORF hasB2 mefE- like
S. pyogenes hasABC      b Phage/plasmid-like element near hasB2
S. equi hasABC  (75)  (63)    
S. uberis hasAB. . . hasCc  (74)  (60)    
S. parauberis hasAB. . . hasCc  (71)  (63)    
S. pneumoniae hasBAC /d (26) /d (56) /d    Transposon elements around hasBAC or hasB
S. suis NAg   (60)     Transposon-like elements near hasB
Enterococcus faecalis  (36)  (50)e   e  Phage/transposon elements around hasAB
S. thermophilus  (36)  (50)     Phage/transposon elements around hasAB
Bacillus cereus hasACB  (51)  (24)     Mobile elements or remnants around hasACB
Bacillus anthracis hasACB  (58)  (24)f  – f  Mobile elements or remnants around hasACB
S. pseudoporcinus NA   (57)    (67) 
Bacillus halodurans      (48) 
Exiguobacterium sibiricum      (49) 
a Percent similarity of homologs was calculated on the amino acid levels.
b Only if present next to hasB2.
c hasC is not adjacent to hasB but the genes are separated by only three ORFs.
d hasB and hasA are present next to hasC in some strains while in others hasB and hasC seem to be separated, and hasA is absent.
e The E. faecalis version of HasB is also 43% similar to HasB2.
f The B. anthracis HasB is 26% similar to S. pyogenes HasB2.
g NA, no operon or genes are not contiguous.
TABLE 3 Pfam comparisons of HasB2 and HasB amino acid domains
Family name (accession no.)a Description
Amino acid region (E value)b
HasB2 HasB
UDPG_MGDP_dh_N (PF03721) UDP-glucose/GDP-mannose dehydrogenase family, NAD binding domain 1–174 (4.5e39) 1–174 (2.6e47)
UDPG_MGDP_dh (PF00984) UDP-glucose/GDP-mannose dehydrogenase family, central domain 187–279 (2.6e25)c 197–290 (2.1e26)d
UDPG_MGDP_dh_C (PF03720) UDP-glucose/GDP-mannose dehydrogenase family, UDP binding domain 297–383 (1.3e09) 313–401 (2.8e11)
a Pfam database.
b Start residue and end residue are indicated.
c Predicted active-site residue, C250.
d Predicted active-site residue, C260.
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levels were analyzed by HA-specific enzyme-linked immunosor-
bent assay (ELISA) (Fig. 4A). The hasB2 mutant exhibited re-
duced capsule production compared to the WT but had levels
significantly higher than either the hasA or hasB strain (Fig.
4A). However, HA synthesis was abolished in the hasB hasB2
double mutant (Fig. 4A), suggesting that hasB2 can contribute to
capsule synthesis, albeit at a reduced level compared to hasB. Re-
vertant hasB2R1 and hasB hasB2R1 strains expressed capsule
levels equivalent to those of the WT and hasB strains, respec-
tively, confirming that the mutations were specific for hasB2 (Fig.
4A). Flow cytometric analysis with biotinylated HA-binding pro-
tein (HABP) revealed that the acapsular hasA strain and hasB
hasB2 strain bound reduced levels of HABP, compared to the
WT,hasB, andhasB2 strains (Fig. 4B), verifying that thehasB
hasB2 strain is capsule deficient. Overall, these data indicate that
HasB is not essential for M1T1 GAS capsule synthesis.
DISCUSSION
GAS is a human pathogen of global significance, causing an array
of mild noninvasive and life-threatening invasive infections. The
GAS cell surface is bound by a thick layer of HA, a glycosamino-
glycan capsule that promotes in vivo survival by circumventing
recognition by the host immune system (14) and increasing resis-
tance to phagocyte-mediated killing (11, 16, 36, 49). The exact role
of HasB, a UDP-glucose 6-dehydrogenase, in GAS HA capsule
biosynthesis remains unclear. Here, we demonstrate that HasB is
not essential for serotype M1T1 GAS capsule synthesis. Using a
combined approach of molecular genetics and bioinformatics, we
identify a putative HasB paralog, termed HasB2, and demonstrate
that this protein exhibits UDP-glucose 6-dehydrogenase activity
in vitro. To our knowledge, this is the first identification of an
enzyme outside the hasABC operon with a demonstrated role in
GAS capsule biogenesis.
Capsule biosynthesis in GAS is coordinated by the universal
and highly conserved hasABC synthase operon (13, 22), originally
identified by Dougherty and van de Rijn through Tn916 trans-
poson mutagenesis of encapsulated serotype M18 GAS (22). Con-
sistent with previous findings (3, 19), we report that mutagenesis
of hasA abolishes HA capsule expression in serotype M1T1 GAS.
Prior evidence for an essential role of HasB was indirect. For ex-
ample, Ashbaugh et al. (3) assumed that hasA and hasB are suffi-
cient for GAS capsule expression based on the observation that
hasC is not required for capsule synthesis. However, neither tar-
geted mutagenesis nor complementation experiments were per-
formed to corroborate these claims. In addition, previous charac-
terization of acapsular Tn916-inactivated transconjugants
identified a deficiency in UDP-glucose dehydrogenase enzymatic
activity, suggesting a key role for hasB in GAS capsule expression
(23, 24). However, the lack of UDP-glucose dehydrogenase activ-
ity was attributed to a polar effect of Tn916::hasA mutation on
hasB expression (23, 24). Finally, insertion of the 16.4-kb Tn916
element into the chromosome may have disrupted the hasABC
promoter region at 35 to 10, a major determinant of capsule
gene expression levels in GAS (1), impeding expression of the
entire hasABC operon. Therefore, the precise contribution of hasB
to capsular HA production in GAS remained ambiguous.
Here, we derived a precise hasB allelic exchange mutant in a
strain representative of the globally disseminated M1T1 serotype
(10). The hasB mutant capsular expression levels were reduced
compared to the level in WT M1T1 GAS, but the levels were sig-
FIG 3 HasB2 is a functional UDP-glucose 6-dehydrogenase. Whole-cell ly-
sates containing recombinant HasB and HasB2 were positive for UDP-glucose
6-dehydrogenase activity, compared to the plasmid-only control, as measured
spectrophotometrically by the reduction of NAD at 340 nm. Data represent the
means standard errors of the means of pooled data from two independent
experiments performed in triplicate. *, P	 0.05; ***, P	 0.001.
FIG 4 HasB2 contributes to GAS capsule biogenesis. (A) Quantitation of capsule expression in the WT, mutant, and revertant strains propagated to mid-log
phase using ELISA (A) and flow cytometric analysis (B) using hyaluronan-binding protein (HABP). ELISA data represent the means standard deviations of
pooled normalized data from two independent experiments performed in duplicate. Flow cytometry data represent means  standard deviations of two
independent experiments. Asterisks indicate values that are statistically significantly different: *, P	 0.05; ***, P	 0.001. bd, below detection.
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nificantly higher than in the acapsular hasA mutant. In contrast
to previous studies (3, 19), these data prove that hasB is not essen-
tial for capsule production in serotype M1T1 GAS. We hypothe-
sized that a hasB paralog (6) may compensate for a nonfunctional
HasB enzyme, thereby providing substrate for capsule biosynthe-
sis in a hasB strain. This hypothesis is supported by previous
observations where HasA and HasB together could reconstitute
HA biosynthesis in acapsular GAS mutants, Enterococcus faecalis,
and Gram-negative E. coli (19). Expression of constructs produc-
ing full-length HasA protein and a nonfunctional truncated HasB
protein resulted in detectable capsule production in E. coli K5,
which contains an endogenous UDP-glucose dehydrogenase.
These data suggest that the E. coliK5 UDP-glucose dehydrogenase
may substitute for the nonfunctional streptococcal HasB enzyme
(19).
Bioinformatic interrogation of the serotype M1T1 GAS
genomic sequence identified a putative HasB paralog, here named
HasB2, with 45% amino acid identity to HasB. Expression of
hasB2 in E. coli generated a protein of approximately 42 kDa, and
whole-cell extracts exhibited similar UDP-glucose 6-dehydroge-
nase activity to HasB control extracts. These data demonstrate
that hasB2 encodes a hitherto unidentified UDP-glucose 6-dehy-
drogenase of GAS. The contribution of hasB2 to M1T1 GAS cap-
sular biogenesis was confirmed by construction and subsequent
analysis of hasB2 mutants. ThehasB2 mutant displayed reduced
capsule expression compared to the WT, but more capsule than
the hasB strain, suggesting that hasB2 plays a secondary role to
hasB in capsule synthesis. Nevertheless, hasB2 does contribute to
HA capsule production, as evidenced by the acapsular phenotype
of the hasB hasB2 double mutant. Complementation of the
single and double hasB2mutants restored capsular expression lev-
els to the WT and hasB strains, respectively, confirming that the
phenotypes are due to specific hasB2 mutations and not to pleio-
tropic mutations or polar effects on gene expression levels.
We used two different HABP-based methodologies (ELISA
and flow cytometry) to quantify capsule production. The ELISA-
based method provided greater sensitivity and a lower back-
ground than the flow method. A possible explanation could be
that hyaluronic acid capsule is not covalently attached to the pep-
tidoglycan cell wall and only loosely associated with the bacterial
surface. Therefore, during sample preparation for flow cytometric
analysis, some capsule may have been lost due to centrifugation at
high force during the wash steps, leaving only the tightly associ-
ated capsule available for staining and reducing the sensitivity of
the assay. In addition, the high background associated with the
flow-based method indicates some level of nonspecific HABP
binding to intact GAS bacteria, as opposed to results using bacte-
rial extracts in the ELISA method. Overall, the conclusion that can
be drawn from these two assays is that hasB is not essential for
capsule production, despite the differences in the absolute level of
contribution.
The bioinformatic and phylogenetic analyses of both the hasB
and hasB2 genes and their associated operons (Fig. 1B and C and
Table 2) suggest a clear distinction between the evolutionary his-
tories of both paralogs. While hasB, often associated with hasA,
seems to be relatively widespread among streptococci (and has
been suggested to have originated from a common streptococcal
ancestor [6]), hasB2 seems to have been more recently acquired
and is present in at least two streptococcal species (GAS and S.
pseudoporcinus). While gene duplication cannot be completely
ruled out as the origin of hasB2, the similarity between the HasB2
proteins of GAS and S. pseudoporcinus is higher than that between
HasB and HasB2 within the same species, suggesting lateral trans-
fer rather than intragenomic duplication. Moreover, the fact that
hasB2, as well as many hasA and hasB orthologs, is often sur-
rounded by mobile element genes like transposon, phage, or plas-
mid-like genes (Tables 1 and 2), supports a scenario where those
genes are horizontally transferred within and between genomes,
perhaps to add functionality to UDP-glucose pyrophosphorylase
genes (hasC homologs) or provide still undefined biochemical
functions. Finally, the presence of hasA and hasB orthologs on the
megaplasmids of Bacillus cereus and Bacillus anthracis (49) (Table
2), which also carry transposable element genes, even more
strongly supports a horizontal origin of these genes.
In summary, we conclude that HasB is a nonessential enzyme
for capsular HA expression in serotype M1T1 GAS. A newly iden-
tified HasB paralog (HasB2) with functional UDP-glucose 6-de-
hydrogenase activity has the capacity to support capsule biosyn-
thesis in the absence of a functional HasB enzyme. The
identification of an auxiliary UDP-glucose 6-dehydrogenase em-
phasizes the indispensable role of capsule in GAS pathogenicity
and demonstrates the impact of horizontal gene transfer and gene
duplication on the evolving virulence potential of microbial
pathogens.
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